WALGREENS BOOTS ALLIANCE, INC.

(WBA)
  Report
Delayed Nasdaq  -  04:00 2022-07-01 pm EDT
38.56 USD   +1.74%
07/01Truist Securities Adjusts Walgreens Boots Alliance's Price Target to $42 from $50, Keeps Hold Rating
MT
07/01UBS Adjusts Walgreens Boots Alliance Price Target to $40 From $42, Maintains Neutral Rating
MT
07/01FACTBOX : Dealmaking hits the rocks due to stormy markets
RE
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
06/27/2022 06/28/2022 06/29/2022 06/30/2022 07/01/2022 Date
42.19(c) 40.96(c) 40.87(c) 37.9(c) 38.56(c) Last
7 140 577 7 825 456 6 099 225 15 611 717 9 291 855 Volume
+1.30% -2.92% -0.22% -7.27% +1.74% Change
More quotes
Estimated financial data (e) (USD)
Sales 2022 132 B - -
Net income 2022 5 329 M - -
Net Debt 2022 9 035 M - -
P/E ratio 2022 6,28x
Yield 2022 4,99%
Sales 2023 135 B - -
Net income 2023 3 390 M - -
Net Debt 2023 7 348 M - -
P/E ratio 2023 9,97x
Yield 2023 5,10%
Capitalization 33 326 M 33 326 M -
EV / Sales 2022 0,32x
EV / Sales 2023 0,30x
Nbr of Employees 315 000
Free-Float 60,9%
More Financials
Company
Walgreens Boots Alliance, Inc. specializes in the distribution of pharmaceutical products. Net sales break down by activity as follows: - retail distribution (83.1%): selling prescription drugs, OTC medicines, beauty and cosmetic products, etc. in the United States (90.1% of net sales) and International (9.9%). At the end of August 2020, the activity is ensured through 13,449 outlets (including 9,021 in the United... 
Sector
Drug Retailers
Calendar
06/30 | 07:00amEarnings Release
More about the company
Ratings of Walgreens Boots Alliance, Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B-
More Ratings
All news about WALGREENS BOOTS ALLIANCE, INC.
07/01Truist Securities Adjusts Walgreens Boots Alliance's Price Target to $42 from $50, Keep..
MT
07/01UBS Adjusts Walgreens Boots Alliance Price Target to $40 From $42, Maintains Neutral Ra..
MT
07/01FACTBOX : Dealmaking hits the rocks due to stormy markets
RE
07/01Deutsche Bank Adjusts Walgreens Boots Alliance Price Target to $44 From $46, Maintains ..
MT
07/01Credit Suisse Lowers Walgreens Boots Alliance's PT to $43 from $52, Notes Limited Visib..
MT
07/01Kohl's ends sale talks with Franchise Group, shares plunge
RE
06/30US Stocks Fall After Consumer Spending Misses Views
MT
06/30Walgreens, Duck Creek fall; Spirit Airlines, Lindsay rise
AQ
06/30US Stocks Drop Thursday on Slower-Than-Expected Consumer Spending, Recession Jitters
MT
06/30S&P 500 closes the book on its steepest first-half slide since 1970
RE
06/30MANAGEMENT'S DISCUSSION AND ANALYSIS Item 2. Management's discussion and analysis of fi..
AQ
06/30S&P 500 closes the book on its biggest first-half plunge since 1970
RE
06/30US STOCKS-S&P 500 wobbles to the end of its worst first-half since 1970
RE
06/30Walgreens Boots Alliance Fiscal Q3 Adjusted EPS, Sales Decline -- Shares Sink Thursday
MT
06/30Equities Drop Midday After Consumption Expenditures Rise Slower Than Expected
MT
More news
News in other languages on WALGREENS BOOTS ALLIANCE, INC.
07/01FACTBOX : Les transactions sont en baisse en raison de la tempête sur les marchés
06/30Les actions américaines chutent après que les dépenses des consommateurs aient manqué l..
06/30Wall Street conclut dans le rouge son pire semestre depuis 1970
06/30Les actions américaines chutent jeudi en raison d'un ralentissement plus important que ..
06/30MÄRKTE USA/Wall Street mit anhaltenden Zinssorgen schwach
More news
Analyst Recommendations on WALGREENS BOOTS ALLIANCE, INC.
More recommendations
Chart WALGREENS BOOTS ALLIANCE, INC.
Duration : Period :
Walgreens Boots Alliance, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends WALGREENS BOOTS ALLIANCE, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 19
Last Close Price 38,56 $
Average target price 44,56 $
Spread / Average Target 15,6%
EPS Revisions
Managers and Directors
Rosalind Gates Brewer Chief Executive Officer & Director
James Kehoe Global Chief Financial Officer & Executive VP
Stefano Pessina Executive Chairman
Francesco Tinto Global Chief Information Officer & Senior VP
Kevin M. Ban Chief Medical Officer
Sector and Competitors